Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men
- PMID: 21819612
- PMCID: PMC3176471
- DOI: 10.1186/1472-6823-11-15
Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men
Abstract
Background: Hyperthyroidism is accompanied by osteoporosis with higher incidence of fracture rates. The present work aimed to study bone status in hyperthyroidism and to elucidate the impact of severity, duration, and etiology of hyperthyroidism on biochemical markers of bone turnover and bone mineral density (BMD).
Methods: Fifty-two male patients with hyperthyroidism, 31 with Graves' disease (GD) and 21 with toxic multinodular goiter (TNG), with an age ranging from 23 to 65 years were included, together with 25 healthy euthyroid men with matched age as a control group. In addition to full clinical examination, patients and controls were subjected to measurement of BMD using dual-energy X-ray absorptiometery scanning of the lower half of the left radius. Also, some biochemical markers of bone turnover were done for all patients and controls.
Results: Biochemical markers of bone turnover: included serum bone specific alkaline phosphatase, osteocalcin, carboxy terminal telopeptide of type l collagen also, urinary deoxypyridinoline cross-links (DXP), urinary DXP/urinary creatinine ratio and urinary calcium/urinary creatinine ratio were significantly higher in patients with GD and TNG compared to controls (P < 0.01). However, there was non-significant difference in these parameters between GD and TNG patients (P > 0.05). BMD was significantly lower in GD and TNG compared to controls, but the Z-score of BMD at the lower half of the left radius in patients with GD (-1.7 ± 0.5 SD) was not significantly different from those with TNG (-1.6 ± 0.6 SD) (>0.05). There was significant positive correlation between free T3 and free T4 with biochemical markers of bone turnover, but negative correlation between TSH and those biochemical markers of bone turnover. The duration of the thyrotoxic state positively correlated with the assessed bone turnover markers, but it is negatively correlated with the Z-score of BMD in the studied hyperthyroid patients (r = -0.68, P < 0.0001).
Conclusion: Men with hyperthyroidism have significant bone loss with higher biochemical markers of bone turnover. The severity and the duration of the thyrotoxic state are directly related to the derangement of biochemical markers of bone turnover and bone loss.
Figures



Similar articles
-
Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time.Clin Endocrinol (Oxf). 1999 Feb;50(2):171-6. doi: 10.1046/j.1365-2265.1999.00626.x. Clin Endocrinol (Oxf). 1999. PMID: 10396358
-
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.Bone. 2004 Sep;35(3):785-91. doi: 10.1016/j.bone.2004.04.021. Bone. 2004. PMID: 15336617
-
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.J Clin Endocrinol Metab. 2000 Nov;85(11):4157-61. doi: 10.1210/jcem.85.11.6979. J Clin Endocrinol Metab. 2000. PMID: 11095447
-
Bone remodelling markers and serum cytokines in patients with hyperthyroidism.Clin Endocrinol (Oxf). 2002 Jul;57(1):125-9. doi: 10.1046/j.1365-2265.2002.01578.x. Clin Endocrinol (Oxf). 2002. PMID: 12100080
-
Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease.Thyroid Res. 2013 Sep 11;6(1):11. doi: 10.1186/1756-6614-6-11. Thyroid Res. 2013. PMID: 24020400 Free PMC article.
Cited by
-
Mechanisms and Treatment Options for Hyperthyroid-Induced Osteoporosis: A Narrative Review.Cureus. 2023 Nov 14;15(11):e48798. doi: 10.7759/cureus.48798. eCollection 2023 Nov. Cureus. 2023. PMID: 38098934 Free PMC article. Review.
-
Evaluation of Bone Turnover Markers Such as Osteoprotegerin, Sclerostin and Dickkopf-1 in Subclinical Hyperthyroidism.Indian J Clin Biochem. 2024 Jan;39(1):130-135. doi: 10.1007/s12291-022-01080-6. Epub 2022 Sep 6. Indian J Clin Biochem. 2024. PMID: 38223003 Free PMC article.
-
The mediating role of thyroid-related hormones between thyroid dysfunction diseases and osteoporosis: a mediation mendelian randomization study.Sci Rep. 2025 Feb 3;15(1):4121. doi: 10.1038/s41598-025-88412-7. Sci Rep. 2025. PMID: 39901040 Free PMC article.
-
Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.Osteoporos Int. 2016 Jan;27(1):115-25. doi: 10.1007/s00198-015-3221-z. Epub 2015 Jul 30. Osteoporos Int. 2016. PMID: 26223189
-
Per- and poly-fluoroalkyl substances and bone mineral density: Results from the Bayesian weighted quantile sum regression.Environ Epidemiol. 2020 Apr 30;4(3):e092. doi: 10.1097/EE9.0000000000000092. eCollection 2020 Jun. Environ Epidemiol. 2020. PMID: 32613152 Free PMC article.
References
-
- Udayakumar N, Chandrasekaran M, Rasheed MH, Suresh RV, Sivaprakash S. Evaluation of bone mineral density in thyrotoxicosis. Singapore Med J. 2006;47(11):947–950. - PubMed
-
- Van de ven AC, Erdtsieck RJ. Changes of bone mineral density, quantitative ultrasound parameters and markers of bone turnover during treatment of hyperthyroidism. The Netherlands J Medicine. 2008;66(10):428–432. - PubMed
LinkOut - more resources
Full Text Sources